BDTX (Black Diamond Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena

BDTX (Black Diamond Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena

BDTXBlack Diamond Therapeutics, Inc.

Mkt Cap$126M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$70M

Net Income (TTM)$21M

EPS (TTM)$0.36

Free Cash Flow (TTM)$21M

Gross Margin99.9%

Op. Margin16.9%

Net Margin30.7%

FCF Margin30.5%

P/S Ratio (TTM)1.8x

P/E Ratio (TTM)5.9x

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$22M
Q1 23	$0	$0	-$22M
Q2 23	$0	$0	-$20M
Q3 23	$0	$0	-$24M
Q4 23	$0	$0	-$21M
Q1 24	$0	-$86K	-$20M
Q2 24	$0	-$86K	-$22M
Q3 24	$0	$0	-$18M
Q4 24	$0	$0	-$18M
Q1 25	$70M	$70M	$55M
Q2 25	$0	-$86K	-$13M
Q3 25	$0	$0	-$11M

Valuation

Quarter	P/S	P/E
Q4 22	—	—
Q1 23	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	—	—
Q1 25	1.8x	24.8x
Q2 25	1.8x	8.7x
Q3 25	1.8x	5.9x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$22M	-$22M
Q1 23	-$20M	-$20M
Q2 23	-$14M	-$14M
Q3 23	-$18M	-$18M
Q4 23	-$14M	-$14M
Q1 24	-$21M	-$21M
Q2 24	-$15M	$0
Q3 24	-$11M	-$11M
Q4 24	-$15M	-$15M
Q1 25	$53M	$53M
Q2 25	-$9M	-$9M
Q3 25	-$8M	-$8M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$0
Q1 23	$0
Q2 23	$0
Q3 23	$33K
Q4 23	$0
Q1 24	$0
Q2 24	$15M
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	—	-16.2%
Q1 23	—	-16.0%
Q2 23	—	-13.6%
Q3 23	—	+8.5%
Q4 23	—	-4.6%
Q1 24	—	-6.1%
Q2 24	—	+10.5%
Q3 24	—	-24.5%
Q4 24	—	-12.4%
Q1 25	—	-23.6%
Q2 25	—	-39.4%
Q3 25	—	-39.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$3M	—
Q1 23	$3M	—
Q2 23	$3M	—
Q3 23	$3M	—
Q4 23	$2M	—
Q1 24	$2M	—
Q2 24	$5M	—
Q3 24	$2M	—
Q4 24	$2M	—
Q1 25	$2M	2.4%
Q2 25	$2M	—
Q3 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A
Q4 22	$15M	$7M
Q1 23	$15M	$7M
Q2 23	$13M	$7M
Q3 23	$16M	$8M
Q4 23	$15M	$6M
Q1 24	$13M	$7M
Q2 24	$12M	$10M
Q3 24	$13M	$5M
Q4 24	$12M	$6M
Q1 25	$11M	$5M
Q2 25	$9M	$4M
Q3 25	$7M	$4M

Revenue Segments

Quarter	Reportable Segment
Q1 25	$70M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$34M	$88M	$123M
Q1 23	$39M	$64M	$103M
Q2 23	$42M	$48M	$90M
Q3 23	$58M	$86M	$144M
Q4 23	$56M	$75M	$131M
Q1 24	$25M	$90M	$115M
Q2 24	$33M	$90M	$123M
Q3 24	$23M	$89M	$113M
Q4 24	$36M	$62M	$99M
Q1 25	$98M	$54M	$152M
Q2 25	$30M	$113M	$143M
Q3 25	$31M	$105M	$136M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	36M	+0.1%
Q1 23	36M	+0.3%
Q2 23	37M	+0.1%
Q3 23	51M	+39.5%
Q4 23	47M	-6.9%
Q1 24	52M	+9.2%
Q2 24	55M	+6.5%
Q3 24	57M	+2.5%
Q4 24	57M	+0.2%
Q1 25	58M	+1.9%
Q2 25	57M	-1.5%
Q3 25	57M	+0.2%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 17	—	—
FY 18	—	—
FY 19	$0	32
FY 20	$0	73
FY 21	$0	88
FY 22	$0	65
FY 23	$0	54
FY 24	$0	24